Results 251 to 260 of about 135,611 (344)
Optic Disc and Retinal Nerve Fibre Layer Changes in Parkinson’s Disease
Ebru Nevin Çetin +4 more
openalex +1 more source
This review summarizes recent advances in metal‐based nanomaterials (MBNs) as multifunctional platforms for next‐generation diagnostics and nanodynamic therapies (NDTs), highlighting their structural tunability, diverse therapeutic modalities, and broad biomedical applications in oncology and infectious disease control.
Qihang Ding +11 more
wiley +1 more source
Refractive Error Correction With Glasses in Congenital Ocular Fundus Anomalies: A Retrospective Series of 18 Children With Different Disease Entities Followed Up for More Than 10 Years. [PDF]
Matsuo T.
europepmc +1 more source
This study introduces glutathione‐stabilized gold nanoparticles for targeted lithium delivery (LiG‐AuNPs), enabling the controlled modulation of Glycogen Synthase Kinase‐3 (GSK‐3β). These non‐toxic, 2‐nm particles release lithium intracellularly, effectively inhibiting GSK‐3β in the brain without significant plasma lithium alterations.
Antonio Buonerba +20 more
wiley +1 more source
Inflammatory optic neuritis and scleritis following commencement of semaglutide: a case report. [PDF]
Maher CB, Guo B, Dunlop AA.
europepmc +1 more source
Optic Nerve Head Hemangioma - An Unusual Presentation of Von Hippel- Lindau Disease
N. A. Vichare
openalex +1 more source
High‐Concentration Antibody Formulation via Solvent‐Based Dehydration
Amorphous solid antibodies are encapsulated into hydrogel microparticles through a solvent‐based dehydration process. The solvent extracts water from antibody solution droplets, causing the antibody to concentrate, and precipitation of the antibody into amorphous solid is induced.
Talia Zheng +3 more
wiley +1 more source
Neurosurgical robot-assisted transnasal endoscopic surgery in orbital-related diseases. [PDF]
Wu R +8 more
europepmc +1 more source

